The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10611 malaria professionals are enjoying the free benefits of MalariaWorld today

Rwanda

History of malaria control in Rwanda: implications for future elimination in Rwanda and other malaria-endemic countries

October 8, 2020 - 08:08 -- Open Access
Author(s): 
Corine Karema, Shawn Wen, Abigail Sidibe, Jennifer L. Smith, Roly Gosling, Emmanuel Hakizimana, Marcel Tanner, Abdisalan M. Noor and Allison Tatarsky
Reference: 
Malaria Journal 2020 19:356, 7 October 2020

Malaria was first reported in Rwanda in the early 1900s with significant heterogeneity and volatility in transmission over subsequent decades. Here, a comprehensive literature review of malaria transmission patterns and control strategies in Rwanda between 1900 and 2018 is presented to provide insight into successes and challenges in the country and to inform the future of malaria control in Rwanda.

Bayesian spatio-temporal modeling of malaria risk in Rwanda

September 15, 2020 - 10:41 -- Open Access
Author(s): 
Semakula M, Niragire FI, Faes C
Reference: 
PLoS One. 2020 Sep 10;15(9):e0238504

Every year, 435,000 people worldwide die from Malaria, mainly in Africa and Asia. However, malaria is a curable and preventable disease. Most countries are developing malaria elimination plans to meet sustainable development goal three, target 3.3, which includes ending the epidemic of malaria by 2030. Rwanda, through the malaria strategic plan 2012-2018 set a target to reduce malaria incidence by 42% from 2012 to 2018.

Why (not) participate in citizen science? Motivational factors and barriers to participate in a citizen science program for malaria control in Rwanda

August 25, 2020 - 15:24 -- Open Access
Author(s): 
Asingizwe D, Poortvliet PM, Koenraadt CJM, van Vliet AJH, Ingabire CM, Mutesa L, Leeuwis C
Reference: 
PLoS One. 2020 Aug 24;15(8):e0237396

This study explores the motivational factors and barriers to participate in a citizen science program for malaria control in Rwanda. It assesses the changes in motivational factors over time and compares these factors among age and gender groups. Using a qualitative approach, this study involved 44 participants. At the initial stage, people participated in the program because of curiosity, desire to learn new things, helping others, and willingness to contribute to malaria control.

What do people benefit from a citizen science programme? Evidence from a Rwandan citizen science programme on malaria control

August 10, 2020 - 14:56 -- Open Access
Author(s): 
Domina Asingizwe, P. Marijn Poortvliet, Arnold J. H. van Vliet, Constantianus J. M. Koenraadt, Chantal M. Ingabire, Leon Mutesa and Cees Leeuwis
Reference: 
Malaria Journal 2020 19:283

Malaria control remains a challenge globally and in malaria-endemic countries in particular. In Rwanda, a citizen science programme has been set up to improve malaria control. Citizens are involved in collecting mosquito species and reporting mosquito nuisance. This study assessed what people benefit from such a citizen science programme. The analysis was conducted on how the citizen science programme influenced perceptions and behaviour related to malaria control.

Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda

August 5, 2020 - 15:14 -- Open Access
Author(s): 
Uwimana A, Legrand E, Stokes BH, Ndikumana JM, Warsame M, Umulisa N, Ngamije D, Munyaneza T, Mazarati JB, Munguti K, Campagne P, Criscuolo A, Ariey F, Murindahabi M, Ringwald P, Fidock DA, Mbituyumuremyi A, Menard D
Reference: 
Nat Med. 2020 Aug 3. doi: 10.1038/s41591-020-1005-2

Artemisinin resistance (delayed P. falciparum clearance following artemisinin-based combination therapy), is widespread across Southeast Asia but to date has not been reported in Africa. Here we genotyped the P. falciparum K13 (Pfkelch13) propeller domain, mutations in which can mediate artemisinin resistance, in pretreatment samples collected from recent dihydroarteminisin-piperaquine and artemether-lumefantrine efficacy trials in Rwanda.

Determinants of the persistence of malaria in Rwanda

January 24, 2020 - 14:53 -- Open Access
Tags: 
Author(s): 
Guillaume Rudasingwa and Sung-Il Cho
Reference: 
Malaria Journal 2020 19:36, 21 January 2020

Malaria has a considerable impact on the health of the populations of developing countries; indeed, the entire population of Rwanda is at risk of contracting the disease. Although various interventions to control malaria have been implemented in Rwanda, the incidence of malaria has increased since 2012. There is an interest in understanding factors driving its persistence in Rwanda. This study aims at evaluating the effect of socio-economic and environmental factors, seasonality and the use of insecticide-treated mosquito nets (ITNs) on malaria persistence in Rwanda.

Subscribe to RSS - Rwanda